Search | Page 7 | AMCP Learn

(R1) The Evolving Role of Patient Experience Data in Formulary and Coverage Decision-Making
(W1) Is Your Organization Ready for AI? A Managed Care Playbook
Tuesday, 10/27 - Sessions from 1:45-2:45pm
(D2) Rare Disease Spotlight: Aligning Medical and Pharmacy Benefits in Neuromuscular Diseases Drugs, Diseases, and the Managed Care Impact
Tuesday, 10/27 - Sessions from 10:15-11:30am
(L2) Federal Legislative and Regulatory Update - Nexus 2026
(M2) Development of High-Impact Algorithms: Unlocking U.S. Payer Data to Improve Patient Outcomes
(R2) Repositioning of Biosimilars: How Can the U.S. Optimize Biosimilar Utilization to Improve Patient Health and Lower Total Cost of Care
(W2) AI in Managed Care Pharmacy: Opportunities, Risks, and Readiness for Decision‑Makers Making the Way for Innovation
An Acute Treatment Option for Migraine: Evidence Across Clinically Relevant Subgroups
Patient Experience Data in Managed Care Pharmacy Decision Making; Barriers, Opportunities, and Practical Strategies for Managed Care Pharmacists
[Promo] Medical Benefits Training: Module 1
RWE Essentials Training Program - Provider & Health Plan Version
RWE Essentials Training Program - Life Sciences Version
AMCP Training Programs - First Module Free
GLP-1’s for Everything! The gift that keeps on giving… A review of the body of evidence and implications for managed care
Specialty Pharmaceuticals in Development 2025
Patient Engagement in Managed Care Pharmacy: Putting Policy into Practice
Unlocking the Value of Real-World Evidence (RWE): Insights for Payers and Manufacturers
Future Horizons: Emerging Trends Impacting Managed Care Pharmacy
Oncology Pipeline 2025: Emerging Breakthroughs and Trends
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice, Managed Care Insights into IgA Nephropathy and Duchenne Muscular Dystrophy
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice, Managed Care Insights into Sickle Cell Disease and Hemophilia
Data Storytelling: Effective Communication with Payers and Other Audiences
Bridging the Gap: Applying the AMCP Real-World Evidence (RWE) Standards to Facilitate Communication Between Manufacturers and Payers

Pages